Abstract:Class switch recombination (CSR) requires activation-induced cytidine deaminase (AID) to trigger DNA double strand breaks (DSBs) at the immunoglobulin heavy chain (IGH) in B cells. Joining of AID-dependent DSBs within IGH facilitate CSR and effective humoral immunity, but ligation to DSBs in non-IGH chromosomes leads to chromosomal translocations. Thus, the mechanism by which AID-dependent DSBs are repaired requires careful examination. The random activity of AID in IGH leads to a spectrum of DSB structures. In this report, we investigated how DSB structure impacts end-joining leading to CSR and chromosomal translocations in human B cells, for which models of CSR are inefficient and not readily available. Using CRISPR/Cas9 to model AID-dependent DSBs in IGH and non-IGH genes, we found that DSBs with 5' and 3' overhangs led to increased processing during end-joining compared to blunt DSBs. We observed that 5' overhangs were removed and 3' overhangs were filled in at recombination junctions, suggesting that different subsets of enzymes are required for repair based on DSB polarity. Surprisingly, while Cas9-mediated switching preferentially utilized NHEJ regardless of DSB structure, A-EJ strongly preferred repairing blunt DSBs leading to translocations in the absence of NHEJ. We found that DSB polarity influenced frequency of Cas9-mediated switching and translocations more than overhang length. Lastly, recombination junctions from staggered DSBs exhibited templated insertions, suggesting iterative resection and filling in during repair. Our results demonstrate that DSB structure biases repair towards NHEJ or A-EJ to complete recombination leading to CSR and translocations, thus helping to elucidate the mechanism of genome rearrangements in human B cells.

The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates.

The RNA-binding Protein ROD1/PTBP3 Cotranscriptionally Defines AID-loading Sites to Mediate Antibody Class Switch in Mammalian Genomes.

Convergent Transcription at Intragenic Super-Enhancers Targets AID-initiated Genomic Instability.

AID/APOBEC Deaminases Disfavor Modified Cytosines Implicated in DNA Demethylation

C-terminal deletion-induced condensation sequesters AID from IgH targets in immunodeficiency

Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice

Transcription elongation factor ELOF1 is required for efficient somatic hypermutation and class switch recombination

Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1

Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination

AID Recruits the RNA Exosome to Degrade HIV ‐1 Nascent Transcripts Through Interaction with the Tat‐P‐ TEF B‐ TAR RNP Complex

REV7 is required for processing AID initiated DNA lesions in activated B cells

Mechanism of noncoding RNA-associated N6-methyladenosine recognition by an RNA processing complex during IgH DNA recombination

B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.

Necessity of HuR/ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification

Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells

Unfolding the symbiosis of AID, chromatin remodelers, and epigenetics-The ACE phenomenon of antibody diversity

The putative RNA helicase DDX1 associates with the nuclear RNA exosome and modulates RNA/DNA hybrids (R-loops)

Aid-Initiated DNA Lesions Are Differentially Processed in Distinct B Cell Differentiation Stages in a Locus-Dependent Manner.

Negative regulation of Activation-Induced Cytidine Deaminase gene transcription in developing B cells by a PU.1-interacting intronic region

DSB structure impacts DNA recombination leading to class switching and chromosomal translocations in human B cells

Mesoscale DNA feature in antibody-coding sequence facilitates somatic hypermutation